171 related articles for article (PubMed ID: 22419115)
1. Re-oxygenation causes hypoxic tumor regression through restoration of p53 wild-type conformation and post-translational modifications.
Gogna R; Madan E; Kuppusamy P; Pati U
Cell Death Dis; 2012 Mar; 3(3):e286. PubMed ID: 22419115
[TBL] [Abstract][Full Text] [Related]
2. TAR1, a human anti-p53 single-chain antibody, restores tumor suppressor function to mutant p53 variants.
Orgad S; Dimant H; Dor-On E; Azriel-Rosenfeld R; Benhar I; Solomon B
J Immunother; 2010; 33(2):146-54. PubMed ID: 20139776
[TBL] [Abstract][Full Text] [Related]
3. Chaperoning of mutant p53 protein by wild-type p53 protein causes hypoxic tumor regression.
Gogna R; Madan E; Kuppusamy P; Pati U
J Biol Chem; 2012 Jan; 287(4):2907-14. PubMed ID: 22147694
[TBL] [Abstract][Full Text] [Related]
4. Regulation of p53 by hypoxia: dissociation of transcriptional repression and apoptosis from p53-dependent transactivation.
Koumenis C; Alarcon R; Hammond E; Sutphin P; Hoffman W; Murphy M; Derr J; Taya Y; Lowe SW; Kastan M; Giaccia A
Mol Cell Biol; 2001 Feb; 21(4):1297-310. PubMed ID: 11158315
[TBL] [Abstract][Full Text] [Related]
5. A single recombinant adenovirus expressing p53 and p21-targeting artificial microRNAs efficiently induces apoptosis in human cancer cells.
Idogawa M; Sasaki Y; Suzuki H; Mita H; Imai K; Shinomura Y; Tokino T
Clin Cancer Res; 2009 Jun; 15(11):3725-32. PubMed ID: 19458054
[TBL] [Abstract][Full Text] [Related]
6. Small-molecule modulators of p53 family signaling and antitumor effects in p53-deficient human colon tumor xenografts.
Wang W; Kim SH; El-Deiry WS
Proc Natl Acad Sci U S A; 2006 Jul; 103(29):11003-8. PubMed ID: 16835297
[TBL] [Abstract][Full Text] [Related]
7. Copper alters the conformation and transcriptional activity of the tumor suppressor protein p53 in human Hep G2 cells.
Tassabehji NM; VanLandingham JW; Levenson CW
Exp Biol Med (Maywood); 2005 Nov; 230(10):699-708. PubMed ID: 16246896
[TBL] [Abstract][Full Text] [Related]
8. Bnip3L is induced by p53 under hypoxia, and its knockdown promotes tumor growth.
Fei P; Wang W; Kim SH; Wang S; Burns TF; Sax JK; Buzzai M; Dicker DT; McKenna WG; Bernhard EJ; El-Deiry WS
Cancer Cell; 2004 Dec; 6(6):597-609. PubMed ID: 15607964
[TBL] [Abstract][Full Text] [Related]
9. The small molecule AU14022 promotes colorectal cancer cell death via p53-mediated G2/M-phase arrest and mitochondria-mediated apoptosis.
Ryu H; Nam KY; Kim JS; Hwang SG; Song JY; Ahn J
J Cell Physiol; 2018 Jun; 233(6):4666-4676. PubMed ID: 29030986
[TBL] [Abstract][Full Text] [Related]
10. Post-translational modifications of p53 tumor suppressor: determinants of its functional targets.
Taira N; Yoshida K
Histol Histopathol; 2012 Apr; 27(4):437-43. PubMed ID: 22374721
[TBL] [Abstract][Full Text] [Related]
11. Selective killing of human breast cancer cells by the styryl lactone (R)-goniothalamin is mediated by glutathione conjugation, induction of oxidative stress and marked reactivation of the R175H mutant p53 protein.
Punganuru SR; Madala HR; Arutla V; Srivenugopal KS
Carcinogenesis; 2018 Dec; 39(11):1399-1410. PubMed ID: 30010803
[TBL] [Abstract][Full Text] [Related]
12. PRIMA-1 inhibits growth of breast cancer cells by re-activating mutant p53 protein.
Liang Y; Besch-Williford C; Hyder SM
Int J Oncol; 2009 Nov; 35(5):1015-23. PubMed ID: 19787255
[TBL] [Abstract][Full Text] [Related]
13. SCO2 induces p53-mediated apoptosis by Thr845 phosphorylation of ASK-1 and dissociation of the ASK-1-Trx complex.
Madan E; Gogna R; Kuppusamy P; Bhatt M; Mahdi AA; Pati U
Mol Cell Biol; 2013 Apr; 33(7):1285-302. PubMed ID: 23319048
[TBL] [Abstract][Full Text] [Related]
14. The p53 target Plk2 interacts with TSC proteins impacting mTOR signaling, tumor growth and chemosensitivity under hypoxic conditions.
Matthew EM; Hart LS; Astrinidis A; Navaraj A; Dolloff NG; Dicker DT; Henske EP; El-Deiry WS
Cell Cycle; 2009 Dec; 8(24):4168-75. PubMed ID: 20054236
[TBL] [Abstract][Full Text] [Related]
15. Influence of tetramerisation on site-specific post-translational modifications of p53: comparison of human and murine p53 tumor suppressor protein.
Warnock LJ; Knox A; Mee TR; Raines SA; Milner J
Cancer Biol Ther; 2008 Sep; 7(9):1481-9. PubMed ID: 18769132
[TBL] [Abstract][Full Text] [Related]
16. p53 acetylation enhances Taxol-induced apoptosis in human cancer cells.
Kim JH; Yoon EK; Chung HJ; Park SY; Hong KM; Lee CH; Lee YS; Choi K; Yang Y; Kim K; Kim IH
Apoptosis; 2013 Jan; 18(1):110-20. PubMed ID: 23161364
[TBL] [Abstract][Full Text] [Related]
17. Surf the post-translational modification network of p53 regulation.
Gu B; Zhu WG
Int J Biol Sci; 2012; 8(5):672-84. PubMed ID: 22606048
[TBL] [Abstract][Full Text] [Related]
18. Andrographolide induces degradation of mutant p53 via activation of Hsp70.
Sato H; Hiraki M; Namba T; Egawa N; Baba K; Tanaka T; Noshiro H
Int J Oncol; 2018 Aug; 53(2):761-770. PubMed ID: 29845212
[TBL] [Abstract][Full Text] [Related]
19. Oxygen-releasing manganese clay hybrid complex triggers p53-mediated cancer cell death in hypoxia.
Deepa ; Mittal A; Taxak S; Tandon V; Pati U
Biochem Pharmacol; 2020 Aug; 178():114054. PubMed ID: 32450254
[TBL] [Abstract][Full Text] [Related]
20. Regulation of p53 activity by HIPK2: molecular mechanisms and therapeutical implications in human cancer cells.
Puca R; Nardinocchi L; Givol D; D'Orazi G
Oncogene; 2010 Aug; 29(31):4378-87. PubMed ID: 20514025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]